SciELO - Scientific Electronic Library Online

 
vol.39 número3Efectos de las estrategias ergo-nutricionales sobre la recuperación en las disciplinas de deportes de combateGuía ESPEN: nutrición clínica en la enfermedad inflamatoria intestinal índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

Links relacionados

  • En proceso de indezaciónCitado por Google
  • No hay articulos similaresSimilares en SciELO
  • En proceso de indezaciónSimilares en Google

Compartir


Nutrición Hospitalaria

versión On-line ISSN 1699-5198versión impresa ISSN 0212-1611

Resumen

HERRERA-MEJIA, Julián et al. Functional feeding to correct gastrointestinal disorders associated with autism spectrum disorders: a systematic review. Nutr. Hosp. [online]. 2022, vol.39, n.3, pp.663-677.  Epub 17-Oct-2022. ISSN 1699-5198.  https://dx.doi.org/10.20960/nh.03898.

Background:

gastrointestinal disorders (GIDs) are common comorbidities in patients with autism spectrum disorders (ASD); treatments with gluten- and casein-free (LGLC) diets or prebiotic/probiotic supplements may reduce the severity of GIDs.

Objective:

to integrate and discuss the evidence on the effectiveness of LGLC diet therapies and prebiotic/probiotic supplements on GIDs in patients with ASD.

Methodology:

the guidelines for the publication of systematic reviews and meta-analyses (PRISMA) were used. Participant characteristics, dietary interventions, prebiotic/prebiotic supplementation, effects of interventions on GIDs, risk of bias, and safety of treatments were analyzed.

Results:

fifteen investigations were analyzed; the prevalence of GIDs among patients with ASD was high (58 %; range, 27-83 %). In more than 20 % of the patients managed with LGLC diets or supplements GID severity decreased (mainly constipation, diarrhea, and abdominal pain). Increases in the counts of beneficial bacteria and a decrease in the proportion of pathogenic bacteria were reported after supplement use. However, all these investigations had significant methodological biases.

Conclusions:

although reductions in the frequency and severity of some GIDs have been found, the effectiveness of these treatments has not been proven yet. Given the methodological differences in the investigations, the design of rigorous studies to evaluate the therapeutic effects of these treatments on gastrointestinal health in patients with ASD is warranted.

Palabras clave : Autism; Gastrointestinal disorders; Intestinal microbiota; Prebiotics; Probiotics; Gluten-free; Casein-free.

        · resumen en Español     · texto en Español     · Español ( pdf )